Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.

June 28, 2020

Kolyma health resort «Talaya» (to its 80th birthday)

Voprosy kurortologii, fizioterapii, i lechebnoĭ fizicheskoĭ kultury
V N ZavgorudkoG V Zavgorudko
July 3, 2020
Open Access

Safety of a Combined WB-EMS and High-Protein Diet Intervention in Sarcopenic Obese Elderly Men

Clinical Interventions in Aging
Wolfgang KemmlerRobert Kob
May 24, 2020
Open Access

Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin

BMJ Case Reports
Cansu Güngör, Udo Carl Wieshmann
May 21, 2020

Non-vitamin K antagonist oral anticoagulants and sport

Minerva cardioangiologica
Silvio RomanoLuigi Sciarra
April 24, 2020

Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity

Circulation Research
Maximilian J SchlossMatthias Nahrendorf
May 28, 2020

Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis

Acta Pharmacologica Sinica
Le-Chun OuJin-Wei Tian
April 28, 2020

Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective

Endocrine, Metabolic & Immune Disorders Drug Targets
Thea MagroneEmilio Jirillo
April 21, 2020
Open Access

Pseudoxanthoma Elasticum: An Interesting Model to Evaluate Chronic Kidney Disease-Like Vascular Damage without Renal Disease

Kidney Diseases
Luis D'MarcoValmore Bermúdez
July 6, 2020

Autophagy in cardiovascular health and disease

Progress in Molecular Biology and Translational Science
Mahmoud AbdellatifSimon Sedej
July 30, 2020

Diabetes, and its treatment, as an effector of autonomic nervous system circuits and its functions

Current Opinion in Pharmacology
Liliana Espinoza, Carie R Boychuk
June 11, 2020

Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system

Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır
Emine AkalınAli Yağız Üresin
May 29, 2020
Open Access

The effect of venlafaxine on blood pressure and ECG in rats fed with high-fat-fructose diet

Interdisciplinary Toxicology
Michaela SasváriováTatiana Stankovičová
April 17, 2020

Targeting senescent cells to attenuate cardiovascular disease progression

Ageing Research Reviews
Ping SongMing-Hui Zou
July 4, 2020

Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions

Journal of Ginseng Research
Muhammad IrfanMan Hee Rhee
June 4, 2020

Cardiac magnetic resonance in cocaine-induced myocardial damage: cocaine, heart, and magnetic resonance

Heart Failure Reviews
Emilia DugoGiovanni Donato Aquaro

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2020 Meta ULC. All rights reserved